Mode
Text Size
Log in / Sign up
N/A Completed N=402 Randomized Double-blind Prevention

Effectiveness Study of Community-Based, Peer-Led Education on Weight Loss and Diabetes

Pre-diabetes
Source: ClinicalTrials.gov NCT01004848 ↗
Enrolled (actual)
402
Serious AEs
—
Results posted
Oct 2014
Primary outcomePrimary: Change in Weight From Baseline to 6 Months — -2.85; -1.13 pounds

Summary

The purpose of this study is to compare the effectiveness of a peer-led community-based lifestyle intervention, versus usual care, in achieving weight loss and prevention of diabetes among overweight adults with pre-diabetes in East Harlem.

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Weight From Baseline to 6 Months
-2.85; -1.13 —
SECONDARY
Change in Fasting Fingerstick Glucose Measurement From Baseline to 6 Months
-1.79; -0.47 —
SECONDARY
Change in Post-prandial Fingerstick Glucose From Baseline to 6 Months
1.41; 3.85 —
SECONDARY
Change in Systolic Blood Pressure From Baseline to 6 Months
-1.39; -1.45 —
SECONDARY
Change in Diastolic Blood Pressure From Baseline to 6 Months
-0.47; -1.07 —
SECONDARY
Waist Circumference
-0.5; -0.29 —
SECONDARY
LDL Cholesterol
-2.93; -1.18 —
SECONDARY
HDL Cholesterol
0.68; .029 —
SECONDARY
Total Cholesterol
-2.78; -0.66 —
SECONDARY
Triglycerides
-0.1; 2.92 —
SECONDARY
HbA1c
0.03; 1.20 —
SECONDARY
Energy Expenditure
-58.08; -12.54 —
SECONDARY
Fiber Intake
-0.19; 0.013 —
SECONDARY
Physical Activity (Self-report)
— —
SECONDARY
Knowledge & Attitudes About Diabetes Risk
— —

Eligibility Criteria

Inclusion Criteria

  • 18 years of age and older
  • Residents of East Harlem or members of an East Harlem Institution in zip codes 10029, 10035, OR in the section of 10037 east of Fifth Avenue
  • BMI ≥ 25 AND pre-diabetes glucose values, defined as fasting fingerstick glucose of 100-125mg/dl and/or glucose 2 hours after an oral glucose load of 140-199 mg/dl
  • Able to communicate verbally to participate in a group education class
  • English or Spanish speaking

Exclusion Criteria

  • < 18 years
  • Previous diagnosis of diabetes
  • BMI <25
  • Fingerstick glucoses outside pre-diabetes level ranges
  • Currently pregnant
  • On medications that may raise or lower blood glucose
  • Cognitive or physical impairment that would preclude comprehension of a conversation and communicating as part of a group (i.e., dementia, deafness, inability to speak)
  • Self-reported terminal illness with life expectancy of less than 1 year
  • Plans to relocate from New York City within one year of enrollment
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01004848). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search